4-methylumbelliferyl β-D-glucoside
Names
[ CAS No. ]:
18997-57-4
[ Name ]:
4-methylumbelliferyl β-D-glucoside
[Synonym ]:
7-hydroxy-4-methyl-8-nitro-chromen-2-one
4-methylumbelliferyl β-D-glucoside
4-Methyl-2-oxo-2H-chromen-7-yl β-D-glucopyranoside
4-methyl-7-hydroxy-8-nitro coumarin
EINECS 228-185-5
4-methyl-8-nitro-7-hydroxycoumarin
4-Methylumbelliferyl-beta-D-glucopyranoside
MFCD00036773
2H-1-Benzopyran-2-one, 7-(β-D-glucopyranosyloxy)-4-methyl-
mutanolysin
7-Hydroxy-4-methyl-8-nitro-cumarin
(4-Methylumbelliferone)-β-D-glucopyranoside
7-hydroxy-4-methyl-8-nitro-coumarin
7-hydroxy-8-nitro-4-methyl-2H-chromen-2-one
4-Methylumbelliferyl β-D-glucopyranoside
Biological Activity
[Description]:
[Related Catalog]:
[Target]
4-Methylumbelliferyl β-D-Glucopyranoside is a fluorogenic substrate for β-glucosidase[1].
[References]
Chemical & Physical Properties
[ Density]:
1.5±0.1 g/cm3
[ Boiling Point ]:
626.9±55.0 °C at 760 mmHg
[ Melting Point ]:
258-263ºC (dec.)
[ Molecular Formula ]:
C16H18O8
[ Molecular Weight ]:
338.309
[ Flash Point ]:
233.9±25.0 °C
[ Exact Mass ]:
338.100159
[ PSA ]:
129.59000
[ LogP ]:
-0.46
[ Vapour Pressure ]:
0.0±1.9 mmHg at 25°C
[ Index of Refraction ]:
1.641
[ Storage condition ]:
2-8°C
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
T+
[ Risk Phrases ]:
26/27/28
[ Safety Phrases ]:
22-24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2932999099
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2932999099
[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
Soft Matter 11 , 5678-87, (2015)
Vacuum ultraviolet (VUV, λ = 172 nm) irradiation of alkyl self-assembled monolayers (SAMs) in the presence of dry air alters their surface properties. In this work, UV photochemically prepared hexadec...
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.J. Clin. Immunol. 35 , 373-83, (2015)
Hematopoietic cell transplantation (HCT) provides a curative therapy for severe forms of primary immunodeficiencies (PID). While the timing and extent of T-cell reconstitution following transplant for...
Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.Pediatr. Blood Cancer 62(3) , 522-8, (2015)
Increasing evidence suggests that early and rapid lymphocyte recovery following allogeneic hematopoietic stem cell transplantation (HSCT) is associated with better survival.We retrospectively analyzed...